Showing results (7551-7560 of 10,388) with videos related to
Sort By:
Pageof 1,039
Vaccines|May 26, 2026
Distribution of Streptococcus pneumoniae Serotypes in Nasopharyngeal Carriage Among Children in Indonesia and Estimated Coverage of Pneumococcal Conjugate Vaccines: A Systematic ReviewAri Prayitno, Mulya Rahma Karyanti, Nina Dwi Putri, et al.Vaccines|May 26, 2026
The Case for Pneumococcal Surface Protein A (PspA): A Comprehensive Review of a Leading Candidate in Pneumococcal Vaccine ResearchBárbara Milani, Nauany Reis Zordan, Rodrigo Hipolito Penha, et al.Vaccines|May 26, 2026
Modern Strategies for Brucellosis Vaccination: From Traditional Approaches to Innovative PlatformsNurika Assanzhanova, Kuandyk Zhugunissov, Olga Chervyakova, et al.Vaccines|November 24, 2019
Efficient Delivery of Dengue Virus Subunit Vaccines to the Skin by Microprojection ArraysDavid A Muller, Alexandra C I Depelsenaire, Ashleigh E Shannon, et al.Vaccines|April 30, 2021
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 VaccinesThai Thanh Hoang Thi, Estelle J A Suys, Jung Seok Lee, et al.Vaccines|December 28, 2021
The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal VaccinationRayen Yanara Valdivia-Olivares, Maria Rodriguez-Fernandez, María Javiera Álvarez-Figueroa, et al.Vaccines|October 26, 2021
Nanotechnology Interventions in the Management of COVID-19: Prevention, Diagnosis and Virus-Like Particle VaccinesAcharya Balkrishna, Vedpriya Arya, Akansha Rohela, et al.Vaccines|February 26, 2022
Vaccination Accelerates Liver-Intrinsic Expression of Megakaryocyte-Related Genes in Response to Blood-Stage MalariaFrank Wunderlich, Denis Delic, Daniela Gerovska, et al.Vaccines|February 26, 2022
An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia-Study ProtocolHelen S Marshall, Prabha H Andraweera, James Ward, et al.Vaccines|August 26, 2022
A U.S. Government-Coordinated Effort to Leverage Non-Human Primate Data to Facilitate Ebolavirus Vaccine DevelopmentKimberly L Taylor, Lynda Lanning, Lawrence Wolfraim, et al.Pageof 1,039